Neonatal jaundice

David Shaw

doi:10.1016/B978-008055232-3.60731-7

Neonatal jaundice

David Shaw

Oral Biology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Neonatal jaundice is a relatively common condition in infants that is due to elevated blood serum concentrations of bilirubin. Jaundice occurs in nearly 90% of all neonates after the first 2-5 days of life and is resolved within two weeks.

Original language	English (US)
Title of host publication	xPharm
Subtitle of host publication	The Comprehensive Pharmacology Reference
Publisher	Elsevier Inc.
Pages	1-4
Number of pages	4
ISBN (Print)	9780080552323
DOIs	https://doi.org/10.1016/B978-008055232-3.60731-7
State	Published - 2007

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics

Access to Document

10.1016/B978-008055232-3.60731-7

Cite this

@inbook{b85149fd4d8046ab878c9accefedb75e,

title = "Neonatal jaundice",

abstract = "Neonatal jaundice is a relatively common condition in infants that is due to elevated blood serum concentrations of bilirubin. Jaundice occurs in nearly 90% of all neonates after the first 2-5 days of life and is resolved within two weeks.",

author = "David Shaw",

year = "2007",

doi = "10.1016/B978-008055232-3.60731-7",

language = "English (US)",

isbn = "9780080552323",

pages = "1--4",

booktitle = "xPharm",

publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Neonatal jaundice

AU - Shaw, David

PY - 2007

Y1 - 2007

N2 - Neonatal jaundice is a relatively common condition in infants that is due to elevated blood serum concentrations of bilirubin. Jaundice occurs in nearly 90% of all neonates after the first 2-5 days of life and is resolved within two weeks.

AB - Neonatal jaundice is a relatively common condition in infants that is due to elevated blood serum concentrations of bilirubin. Jaundice occurs in nearly 90% of all neonates after the first 2-5 days of life and is resolved within two weeks.

UR - http://www.scopus.com/inward/record.url?scp=84884094559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884094559&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.60731-7

DO - 10.1016/B978-008055232-3.60731-7

M3 - Chapter

AN - SCOPUS:84884094559

SN - 9780080552323

SP - 1

EP - 4

BT - xPharm

PB - Elsevier Inc.

ER -

Neonatal jaundice

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this